{
"id":"mk19_bb_hm_s17",
"subspecialtyId":"hm",
"title":"Approach to Bleeding Disorders",
"jsonContent":{
"type":"section",
"id":"mk19_bb_hm_s17",
"title":{
"__html":"Approach to Bleeding Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"b455d6",
"children":[
"Approach to Bleeding Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_hm_s17_1",
"title":{
"__html":"Diagnosis and Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"d7f1cf",
"children":[
"Diagnosis and Testing"
]
},
"children":[
{
"type":"p",
"hlId":"813650",
"children":[
"Bleeding disorders are characterized by defects in primary and secondary hemostasis. Primary hemostasis involves the formation of a platelet plug at the site of vascular disruption. Secondary hemostasis is initiated by the exposure of tissue factor at the site of vascular damage and the initiation of the coagulation cascade."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"efe786",
"children":[
"Primary hemostasis failure is characterized by mucocutaneous bleeding (epistaxis, gingival bleeding, easy bruising, and menorrhagia)."
]
},
" ",
{
"type":"list-item",
"hlId":"145216",
"children":[
"Secondary hemostasis failure is characterized by bleeding into muscles and joints as well as delayed bleeding."
]
},
" ",
{
"type":"list-item",
"hlId":"cfef81",
"children":[
"Excessive bleeding after childbirth, surgery, or trauma can occur in either category."
]
},
" "
]
},
{
"type":"p",
"hlId":"b00947",
"children":[
"The following tests are used when evaluating bleeding disorders:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"6d52c2",
"children":[
{
"type":"abbreviation",
"title":"prothrombin time",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"PT"
]
}
]
},
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" and "
]
},
{
"type":"abbreviation",
"title":"activated partial thromboplastin time",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"aPTT"
]
}
]
},
" monitor for factor deficiencies and factor inhibitors."
]
},
" ",
{
"type":"list-item",
"hlId":"7ee184",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Mixing study"
]
},
" differentiates factor deficiency from factor inhibitor by mixing patient plasma with normal plasma and retesting the PT and aPTT."
]
},
" ",
{
"type":"list-item",
"hlId":"8295b1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Bleeding time"
]
},
" identifies platelet disorders and vessel-wall integrity; a commercially available platelet function test also assesses platelet function."
]
},
" ",
{
"type":"list-item",
"hlId":"3f6936",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Thrombin time"
]
},
" tests the conversion of fibrinogen to fibrin."
]
},
" ",
{
"type":"list-item",
"hlId":"7bcb9e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Fibrinogen, fibrinogen degradation products, and D-dimer"
]
},
" are used to identify excessive fibrinolysis."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
}
}